Description
LOPERAMIDE CHI CAPSULES MOD #14 INCORPORATES TEVA CY11 SUB-CONTRACTING PLAN
Base award description: LOPERAMIDE CAPSULES
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2007-11-14+$0= $0
- Mod 32007-11-30+$0= $0
- Mod 62008-01-17+$0= $0
- Mod 72008-03-21+$0= $0
- Mod 82008-11-05+$0= $0
- Mod 92009-02-04+$0= $0
- Mod 102009-11-19+$0= $0
- Mod 112010-03-12+$0= $0
- Mod 122010-10-21+$0= $0
- Mod 132010-11-02+$0= $0
- Mod 142011-03-28+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base· EXERCISE AN OPTION | 2007-11-14 | +$0 | $0 | LOPERAMIDE CAPSULES |
| Mod 3· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2007-11-30 | +$0 | $0 | LOPERAMIDE CAPSULES MOD #3 INCORPORATES 0.25% COST RECOVERY FEE |
| Mod 6· OTHER ADMINISTRATIVE ACTION | 2008-01-17 | +$0 | $0 | LOPERAMIDE CAPSULES MOD #6 INCORPORATES TEVA CY08 SUB-CONTRACTING PLAN |
| Mod 7· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2008-03-21 | +$0 | $0 | LOPERAMIDE CAPSULES MOD #7 INCREASES COST RECOVERY FEE FROM 0.25% TO 0.50% |
| Mod 8· EXERCISE AN OPTION | 2008-11-05 | +$0 | $0 | LOPERAMIDE CHI CAPSULES |
| Mod 9· OTHER ADMINISTRATIVE ACTION | 2009-02-04 | +$0 | $0 | LOPERAMIDE CAPSULES MOD #9 INCORPORATES TEVA CY09 SUB-CONTRACTING PLAN |
| Mod 10· EXERCISE AN OPTION | 2009-11-19 | +$0 | $0 | LOPERAMIDE CHI CAPSULES |
| Mod 11· OTHER ADMINISTRATIVE ACTION | 2010-03-12 | +$0 | $0 | LOPERAMIDE CHI CAPSULES MOD #11 INCORPORATES TEVA CY10 SUB-CONTRACTING PLAN |
| Mod 12· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2010-10-21 | +$0 | $0 | LOPERAMIDE CHL CAPSULES MOD #12 ADDS LOVELL FHCC AS AUTHORIZED PARTICIPANT |
| Mod 13· EXERCISE AN OPTION | 2010-11-02 | +$0 | $0 | LOPERAMIDE CHL CAPSULES |
| Mod 14· OTHER ADMINISTRATIVE ACTION | 2011-03-28 | +$0 | $0 | LOPERAMIDE CHI CAPSULES MOD #14 INCORPORATES TEVA CY11 SUB-CONTRACTING PLAN |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NEN9A34LRHJ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0125 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79723D0023 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79722D0021 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| VA797E17A0007 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2018 |
| V797D70217 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
| VA797E17C0034 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
Other recipients under 6505 from DEPT OF VETERANS AFFAIRS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA797P16J0052 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $71,957 | FY2016 |
| VA797P16J0053 | EXCELLIUM PHARMACEUTICAL INC. | DEPT OF VETERANS AFFAIRS | $69,294 | FY2016 |
| VA797P16J0051 | AMNEAL PHARMACEUTICALS OF NEW YORK, LLC | DEPT OF VETERANS AFFAIRS | $227,935 | FY2016 |
| VA797P16J0050 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $22,663 | FY2016 |
| VA797P16J0049 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $32,995 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797P0036_3600 · retrieved 2026-09-26.